Andromède
Also known as Andromède SAS, Andromede
Paris holding company of the Hériard Dubreuil family; majority owner of Rémy Cointreau and holder of stakes in Oeneo, The Webster, mdGroup, Alboran and EthiFinance.
USEFUL FOR Co-investors
Paris holding company of the Hériard Dubreuil family (Rémy Cointreau). Not to be confused with other French companies named Andromède.
Family & background
- FAMILY
- Hériard Dubreuil
- WEALTH ORIGIN
- Rémy Martin cognac / Rémy Cointreau
- HEADQUARTERS
- Paris, France
- FOUNDED
- 1977
Investment approach
- SECTORS
- Consumer & E-commerce
- ROUTES
- Companies (own capital)
Overview
Andromède SAS is the holding company of the Hériard Dubreuil family, based at 25 rue Balzac in Paris. Rémy Cointreau describes it as the family holding that holds majority control of the listed spirits group, which is consolidated in the Andromède group. Its website lists six group companies: Rémy Cointreau, Oeneo, The Webster, mdGroup, Alboran and EthiFinance. In June 2020 it became majority shareholder of the rating agency Qivalio, whose ESG arm was EthiFinance, through a capital increase.
Holdings & investments (6)
- Rémy CointreauNOTABLEConsumer & E-commerce
- Consumer & E-commerce
Frequently asked questions
Andromède is a family holding based in Paris, France, founded in 1977.
Andromède invests on behalf of the Hériard Dubreuil family (Rémy Martin cognac / Rémy Cointreau).
Andromède invests its own capital into companies.
Andromède invests in Consumer & E-commerce.
Andromède's holdings and investments include Rémy Cointreau, Oeneo, The Webster, mdGroup, Alboran and EthiFinance.
The most recent publicly reported investment by Andromède is Qivalio (Capital increase; Andromède became majority shareholder), announced in Jun 2020.